The global anatomic pathology market size is estimated to reach around US$ 24 billion by 2026 and growing at CAGR of 6% over the forecast period 2019 to 2026

LOS ANGELES, July 17, 2019 (GLOBE NEWSWIRE) — Acumen Research and Consulting recently published a report titled “Anatomic Pathology Market (By Product and Service: Consumables [Reagents & Antibodies, Probes & Kits, Others], Instruments [Tissue processors, Automatic Stainers, Microtomes & Cryostat, Others], Services; By Application: Drug Discovery & Development, Disease Diagnosis, Others; By End-use: Hospitals, Diagnostic Laboratories, Research Laboratories, Others) – Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 – 2026”.

Free Download Sample Report Pages for Better [email protected]

Technology is expected to boost the adoption rate of sophisticated anatomical pathological devices in tools and protocols used during anatomical pathology. The integration of healthcare informatics norms by improving effectiveness and reducing expenses is a driving factor for the industry. Market actors cooperate in pathology laboratory renovation with the incorporation of innovative models for diagnosing diseases. This in turn speeds up investments in pathological machinery upgrading.

Thermo Fisher and Leica Microsystems worked together in April 2018 to develop an integrated workflow for studying cryo-tomography. Within the framework of this partnership, the businesses combined their current technology to provide improved microscopic alternatives that are user friendly and reliable, allowing scientists to obtain insights into biological procedures.

The anatomical pathology market is supported by pathology-trainee programs provided by government and private bodies to pathologists. Some of the associations which started various training programs and exams for the evaluation of a pathologist’s skill and understanding are the Royal College of Pathologists and the General Medical Council and the Association of Anatomical Pathology Technology.

View Detailed Information with Complete [email protected]

Key Highlights

The Diagnostics Laboratories segment is anticipated to achieve the fastest growth rate with technological developments in tools to minimize the danger of mistakes by integrating novel designs. 

The dominant income share of the consumables has been ascribed to high availability, low costs and frequent buy rates of consumables such as reagents and samples. 

The scholarly study sector has been driven by the increased application of anatomical pathology processes in studies like tumor examination and biomarker profiling.

The shift from standard to custom medicine has led to the fastest growth of the drug discovery and development sector. This is mainly because findings of alleged biomarkers are increasingly being relied upon to develop personalisation. 

The biggest share of hospitals has been contributed by increasing hospitalization rates which stimulates the implementation of pathological workflows for disease monitoring and diagnosis. 

On the other side, the development of the diagnostic lab segment is enhanced by the use of advanced laboratory devices and instruments, various electronic interfaces and IT systems.

In addition to a big amount of government financing programs, the presence of important players like Thermo Fisher and Agilent contributes to the biggest proportion in North America. 

Asia Pacific is anticipated to show the highest development in the industry of anatomic pathology driven by the existence of numerous organizations involved in pathology practice.

Browse all official Market Research Reports Press [email protected]

Explore Our Market [email protected]

The diagnosis of multiple infectious diseases, multiple cancer types as well as medical circumstances involves anatomical pathology by examining tissues and cells samples from the biopsy report. Increasingly aging, chronic illnesses are on the rise, and expensive healthcare are all showing favorable development in this industry. This has recently improved the need for the market for anatomic pathology. In the coming years, the nations with the highest amount of older populations will develop the market for anatomical pathology. Technological advances will also function as the driving force for this industry in the healthcare industry.

Key Players & Strategies

Some of the key players are Laboratory Corporation of America Holdings; Thermo Fisher Scientific, Inc.; Sakura Finetek USA, Inc.Cardinal Health, Inc.; Agilent Technologies, Inc.; F. Hoffmann-La Roche AG; Quest Diagnostics Incorporated; BioGenex; NeoGenomics Laboratories, Inc.; and Bio SB.

These main players implement various approaches in order to retain their important market share during the forecast period. Collaborative development, corporate development and product development are the strategies introduced.

For instance, in June 2018, Agilent Technologies introduced a range of probes, such as MALT1, MYC, BCL6, BCL2, CCND1, IGH, IGH / BCL2, IGH / MYC, and IGH /CCND1, for in situ hybridization. The launch of these products has improved the portfolio of the company and thus reinforced its place in the industry.

Acumen Research and Consulting Enters Partnership with MARKETWATCH, Click Here

Request for [email protected]

The report is readily available and can be dispatched immediately after payment confirmation.

Buy this premium research report –

If you would like to place an order or have any questions, please feel free to contact at [email protected] | +1 407 915 4157

For Latest Update Follow Us: